M-134, a novel HDAC6-selective inhibitor, markedly improved arthritic severity in a rodent model of rheumatoid arthritis when combined with tofacitinib
Titel:
M-134, a novel HDAC6-selective inhibitor, markedly improved arthritic severity in a rodent model of rheumatoid arthritis when combined with tofacitinib
Auteur:
Bae, Daekwon Choi, Youngil Lee, Jiyoung Ha, Nina Suh, Donghyeon Baek, Jiyeon Park, Jinsol Son, Woochan